Abdulkadyrov Km

3.6k total citations
87 papers, 996 citations indexed

About

Abdulkadyrov Km is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Abdulkadyrov Km has authored 87 papers receiving a total of 996 indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Hematology, 41 papers in Genetics and 13 papers in Molecular Biology. Recurrent topics in Abdulkadyrov Km's work include Chronic Myeloid Leukemia Treatments (28 papers), Chronic Lymphocytic Leukemia Research (24 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers). Abdulkadyrov Km is often cited by papers focused on Chronic Myeloid Leukemia Treatments (28 papers), Chronic Lymphocytic Leukemia Research (24 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers). Abdulkadyrov Km collaborates with scholars based in Russia, United States and Poland. Abdulkadyrov Km's co-authors include Genadi Iosava, Michael Hedenus, Diethelm Messinger, Yvonne Brandberg, Anders Österborg, Ofer Shpilberg, Antonio Palumbo, Andrew Cakana, Jesús F. San Miguel and Martin Kropff and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Abdulkadyrov Km

74 papers receiving 967 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abdulkadyrov Km Russia 11 776 417 391 282 88 87 996
Mario Annunziata Italy 17 592 0.8× 141 0.3× 202 0.5× 255 0.9× 65 0.7× 51 776
Matteo Molica Italy 16 487 0.6× 163 0.4× 253 0.6× 341 1.2× 77 0.9× 70 773
Isamu Sugiura Japan 17 905 1.2× 187 0.4× 172 0.4× 293 1.0× 95 1.1× 80 1.2k
RM Stone United States 9 570 0.7× 215 0.5× 282 0.7× 123 0.4× 130 1.5× 13 940
Joan Besalduch Spain 20 868 1.1× 408 1.0× 464 1.2× 327 1.2× 239 2.7× 44 1.4k
Debra M. Bensen-Kennedy United States 12 389 0.5× 113 0.3× 142 0.4× 146 0.5× 33 0.4× 19 652
Abelardo Bárez Spain 17 513 0.7× 226 0.5× 386 1.0× 309 1.1× 175 2.0× 42 918
Kunitake Hirashima Japan 14 410 0.5× 126 0.3× 218 0.6× 113 0.4× 26 0.3× 44 698
Agnès Guerci France 19 1.9k 2.5× 247 0.6× 463 1.2× 1.3k 4.8× 154 1.8× 49 2.1k
Ankur R. Parikh United States 8 583 0.8× 134 0.3× 139 0.4× 138 0.5× 36 0.4× 15 861

Countries citing papers authored by Abdulkadyrov Km

Since Specialization
Citations

This map shows the geographic impact of Abdulkadyrov Km's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdulkadyrov Km with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdulkadyrov Km more than expected).

Fields of papers citing papers by Abdulkadyrov Km

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdulkadyrov Km. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdulkadyrov Km. The network helps show where Abdulkadyrov Km may publish in the future.

Co-authorship network of co-authors of Abdulkadyrov Km

This figure shows the co-authorship network connecting the top 25 collaborators of Abdulkadyrov Km. A scholar is included among the top collaborators of Abdulkadyrov Km based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdulkadyrov Km. Abdulkadyrov Km is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shuvaev, Vasily, et al.. (2017). Genetic Markers of Hereditary Thrombophilia and Risk of Thrombotic Complications in Patients with Polycythemia Vera. Clinical oncohematology. 10(1). 85–92. 3 indexed citations
3.
Shuvaev, Vasily, et al.. (2017). Molecular Genetic Markers and Clinical Characteristics of Essential Thrombocythemia. Clinical oncohematology. 10(3). 402–408.
5.
Km, Abdulkadyrov, et al.. (2015). Primary myelofibrosis: own experience and news from diagnostic and treatment. SHILAP Revista de lepidopterología. 1 indexed citations
6.
Km, Abdulkadyrov, et al.. (2015). Primary Incidence of Hematological Malignancies in Saint Petersburg in 1990–2011 and Prognosis till 2021. SHILAP Revista de lepidopterología. 8(4). 362–367. 1 indexed citations
7.
Km, Abdulkadyrov, et al.. (2015). Modern Approaches to Diagnosis and Treatment of Essential Thrombocythemia: Literature Review and Own Experience. SHILAP Revista de lepidopterología. 8(3). 235–247. 1 indexed citations
8.
9.
Shuvaev, Vasily, et al.. (2015). Pharmacoeconomic modeling of target therapy of chronic myeloid leukemia in remission. SHILAP Revista de lepidopterología. 1 indexed citations
10.
Shuvaev, Vasily, et al.. (2015). Pharmacoeconomical Analysis of Chronic Myelogenous Leukemia Treatment Free Remission. Blood. 126(23). 3293–3293. 5 indexed citations
11.
Lomaia, Elza, et al.. (2015). Efficacy of Tyrosine Kinase Inhibitors in Third Line Therapy in Chronic Phase Chronic Myeloid Leukemia. Blood. 126(23). 4051–4051. 10 indexed citations
12.
Robak, Tadeusz, Sebastian Grosicki, Krzysztof Warzocha, et al.. (2015). Ofatumumab (O) in combination with fludarabine (F) and cyclophosphamide (C) (OFC) vs. FC in patients with relapsed chronic lymphocytic leukaemia (CLL): results of the phase III study complement 2. Haematologica. 100. 3 indexed citations
13.
Km, Abdulkadyrov, et al.. (2014). Imatinib Generics: Myths and Reality (Literature Review and Our Experience). Clinical oncohematology. 7(3). 311–316. 1 indexed citations
14.
Km, Abdulkadyrov, et al.. (2014). The specific features of the immunophenotype of blast cells in patients with de novo normal karyotype acute myeloid leukemia and FLT3-ITD mutation. SHILAP Revista de lepidopterología. 1 indexed citations
15.
Km, Abdulkadyrov, et al.. (2014). Heterogeneity of acute myeloid leukemia with the translocation t(8;21)(q22;q22). SHILAP Revista de lepidopterología. 1 indexed citations
16.
Shuvaev, Vasily, et al.. (2014). Tyrosine kinase inhibitors therapy related neutropenia and thrombocythopenia correction in CML patients. SHILAP Revista de lepidopterología. 2 indexed citations
17.
Km, Abdulkadyrov, et al.. (2013). Selection of patients for iron-chelating therapy. SHILAP Revista de lepidopterología. 6(2). 204–209. 1 indexed citations
18.
Shuvaev, Vasily, et al.. (2013). PRIMARY MYELOFIBROSIS - A SURVEY BASED ON THE 20-YEARS' EXPERIENCE OF A SINGLE CENTER. Haematologica. 98. 624–624. 2 indexed citations
19.
Km, Abdulkadyrov, et al.. (2013). Time course of changes in iron metabolic and oxidative-antioxidative system parameters in patients with acute myeloid leukemia. SHILAP Revista de lepidopterología. 1 indexed citations
20.
Km, Abdulkadyrov, et al.. (1996). Renal Insufficiency in Multiple Myeloma: Basic Mechanisms in Its Development and Methods for Treatment. Renal Failure. 18(1). 139–146. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026